G Square Closes £500M Continuation Fund for Pharmacy2U
G Square Healthcare Private Equity LLP has closed a £500 million single-asset continuation fund for Pharmacy2U. This transaction marks a significant GP-led secondary investment in the European health-tech sector, aimed at supporting Pharmacy2U's growth and innovation strategies.
Theia Market Signal Identification - AI Assisted
G Square has successfully launched a £500 million continuation fund for Pharmacy2U, the UK's foremost online pharmacy. The fund, led by Coller Capital and backed by institutional investors, aims to enhance Pharmacy2U's capabilities through continued M&A, technology investment, and service expansion.
Significant achievements include six acquisitions completed over the past two years and investments in dispensing automation. This move provides liquidity for existing partners while allowing continued involvement for those wishing to maintain their stake. The transaction highlights strong investor confidence in the healthcare sector and G Square's strategic focus on this market.
Comments